Grifols SA agreed to pay about $1.9 billion for a stake in Shanghai RAAS Blood Products Co., gaining a major foothold in China’s booming blood-products market.
privacy policy | terms of use | contact us | advertise | pharma jobs | pharma blogs | facebook | twitter
Copyright © 2024,